- Home
- OGEN vs CREG Comparison
OGEN vs CREG Comparison
Compare OGEN & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- CREG
- Stock Information
- Founded
- OGEN 1996
- CREG N/A
- Country
- OGEN United States
- CREG China
- Employees
- OGEN N/A
- CREG N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- CREG Power Generation
- Sector
- OGEN Health Care
- CREG Utilities
- Exchange
- OGEN Nasdaq
- CREG Nasdaq
- Market Cap
- OGEN 5.0M
- CREG 4.7M
- IPO Year
- OGEN N/A
- CREG N/A
- Fundamental
- Price
- OGEN $1.28
- CREG $1.65
- Analyst Decision
- OGEN
- CREG
- Analyst Count
- OGEN 0
- CREG 0
- Target Price
- OGEN N/A
- CREG N/A
- AVG Volume (30 Days)
- OGEN 112.2K
- CREG 259.4K
- Earning Date
- OGEN 11-12-2025
- CREG 11-07-2025
- Dividend Yield
- OGEN N/A
- CREG N/A
- EPS Growth
- OGEN N/A
- CREG N/A
- EPS
- OGEN N/A
- CREG N/A
- Revenue
- OGEN N/A
- CREG $82,839.00
- Revenue This Year
- OGEN N/A
- CREG N/A
- Revenue Next Year
- OGEN N/A
- CREG N/A
- P/E Ratio
- OGEN N/A
- CREG N/A
- Revenue Growth
- OGEN N/A
- CREG N/A
- 52 Week Low
- OGEN $1.01
- CREG $1.11
- 52 Week High
- OGEN $18.90
- CREG $14.70
- Technical
- Relative Strength Index (RSI)
- OGEN 54.57
- CREG 53.34
- Support Level
- OGEN $1.02
- CREG $1.11
- Resistance Level
- OGEN $1.34
- CREG $1.86
- Average True Range (ATR)
- OGEN 0.07
- CREG 0.15
- MACD
- OGEN 0.05
- CREG -0.04
- Stochastic Oscillator
- OGEN 81.82
- CREG 88.71
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.